Search Results 251-260 of 34607 for oral

1. A Study Of Budesonide Oral Suspension With Subcutaneous Dupilumab On Esophageal Diameter And Fibrotic Change In EOE - Mayo Clinic

   The purpose of this study is to determine the effect of dupilumab versus budesonide suspension on esophageal diameter in patients with EoE. Participation ...

2. Jaw surgery - Care at Mayo Clinic

   Mayo Clinic oral, jaw and face surgeons (maxillofacial surgeons) and orthodontists have vast experience in treating complex jaw conditions. They have ...

3. Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution (ZX008)as Adjunctive Therapy In Children With Intractable Epilepsy With Myoclonic-Atonic Seizures - Mayo Clinic

   Study Evaluating The Safety And Efficacy Of Fenfluramine Hydrochloride Oral Solution (ZX008)as Adjunctive Therapy In Children With Intractable Epilepsy With ...

4. A Study of Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumors that are Recurrent or Cannot Be Removed by Surgery - Mayo Clinic

   Treatment with oral/systemic corticosteroids, with the exception of topical or inhaled steroids; Current exposure to household contacts ≤ 15 months old or ...

5. Oral lichen planus - Symptoms and causes - Mayo Clinic

   Oral lichen planus (LIE-kun PLAY-nus) is an ongoing inflammatory condition that affects mucous membranes inside the mouth. There are several different types ...

6. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   The study will evaluate oral daily administration of eFT508. Treatment and study subject evaluation will be performed in 21-day cycles. Participation ...

7. Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma - Mayo Clinic

   Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin ...

8. A Study Comparing Treatment with Oral Solution versus the Standard Intravenous Fluid Therapy for Acute Dehydration in Adults - Mayo Clinic

   The purpose of this study is to compare the efficiency and patient acceptability of treatment with an oral rehydration solution versus the standard intravenous ...

9. A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies - Mayo Clinic

   A Study to Evaluate the Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia with Lewy Bodies · Overview · Participation eligibility.

10. Ondansetron (oral route, oromucosal route) - Mayo Clinic

    For oral dosage forms (oral disintegrating tablets, solution, or tablets):. For prevention of moderate nausea and vomiting after treatment with cancer ...